EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Point of care testing for the diagnosis of periprosthetic joint infections: a review

Pavlos Altsitzioglou, Konstantinos Avgerinos, Vasileios Karampikas, Panayiotis Gavriil, Apostolos Vlachos, Fotini Soucacou, Ioannis Zafiris, Vasileios Kontogeorgakos, Panayiotis J Papagelopoulos, Andreas F Mavrogenis

SICOT-J · 2024 · 10 · 24

DOI: 10.1051/sicotj/2024019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SICOT-J, online erschienen am 07.06.2024. Verfasst von Pavlos Altsitzioglou und 9 weiteren Autor:innen. Beteiligte Einrichtung: From the First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periprosthetic joint infection (PJI) remains a major complication following total joint arthroplasties (TJA), significantly affecting patient outcomes and healthcare costs. Despite advances in diagnostic techniques, challenges persist in accurately diagnosing PJI, underscoring the need for effective point-of-care testing (POCT).

Methods

This review examines the current literature and latest developments in POCT for diagnosing PJI, focusing on biomarkers such as alpha-defensin, leukocyte esterase, calprotectin, and C-reactive protein (CRP). Criteria from various societies like the Musculoskeletal Infection Society, Infectious Diseases Society of America, and the International Consensus Meeting were compared to evaluate the effectiveness of these biomarkers in a point-of-care setting.

Results

POCT provides rapid results essential for the timely management of PJI, with alpha-defensin and leukocyte esterase showing high specificity and sensitivity. Recent advancements have introduced novel biomarkers like calprotectin, which demonstrate high diagnostic accuracy. However, challenges such as the variability in test performance and the need for validation under different clinical scenarios remain.

Discussion

While POCT for PJI shows promising results, their integration into clinical practice requires standardized protocols and further validation. The evolution of these diagnostic tools offers a potential shift toward more personalized and immediate care, potentially improving outcomes for patients undergoing TJA.

Schlagwörter

Stichwörter der Autor:innen

Alpha-defensinCRPCalprotectinLeukocyte esterasePJIPoint of care testing

Autor:innen und Institutionen

  • From the First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Zitieren

APA

Altsitzioglou, P., Avgerinos, K., Karampikas, V., Gavriil, P., Vlachos, A., Soucacou, F., Zafiris, I., Kontogeorgakos, V., Papagelopoulos, P. J., & Mavrogenis, A. F. (2024). Point of care testing for the diagnosis of periprosthetic joint infections: a review. SICOT-J, 10, 24. https://doi.org/10.1051/sicotj/2024019

Vancouver

Altsitzioglou P, Avgerinos K, Karampikas V, Gavriil P, Vlachos A, Soucacou F, et al. Point of care testing for the diagnosis of periprosthetic joint infections: a review. SICOT-J. 2024;10:24. doi:10.1051/sicotj/2024019

BibTeX
@article{Altsitzioglou2024,
  author = {Altsitzioglou, Pavlos and Avgerinos, Konstantinos and Karampikas, Vasileios and Gavriil, Panayiotis and Vlachos, Apostolos and Soucacou, Fotini and Zafiris, Ioannis and Kontogeorgakos, Vasileios and Papagelopoulos, Panayiotis J and Mavrogenis, Andreas F},
  title = {Point of care testing for the diagnosis of periprosthetic joint infections: a review},
  journal = {SICOT-J},
  year = {2024},
  volume = {10},
  pages = {24},
  doi = {10.1051/sicotj/2024019}
}
Kostenlos starten →